Pharmaceuticals and the developing world

被引:115
作者
Kremer, M [1 ]
机构
[1] Harvard Univ, Cambridge, MA 02138 USA
关键词
D O I
10.1257/089533002320950984
中图分类号
F [经济];
学科分类号
02 ;
摘要
Pharmaceuticals have greatly improved health in developing countries, but many people in developing countries do not obtain even inexpensive pharmaceuticals and little pharmaceutical R&D is oriented toward products needed by developing countries, such as a malaria vaccine. Access to existing products could be improved by facilitating differential pricing, for example by subsidizing donation programs, and reforming health care delivery. R&D incentives could be improved if rich countries or international organization committed to purchase needed products when they are developed and make them available to the poor.
引用
收藏
页码:67 / 90
页数:24
相关论文
共 59 条
[1]  
ADAMS G, 2001, CONSENSUS STATEMENT
[2]  
Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006
[3]  
[Anonymous], 2020, 2020 DEV 3 WGI PROT
[4]  
[Anonymous], 2001, The world health report-mental health: New understanding, new hope
[5]  
[Anonymous], 2000, World Health Report 2000: Health Systems: Improving Performance
[6]  
[Anonymous], ECONOMIST
[7]  
[Anonymous], PATENT POLICY PROPOS
[8]   Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa? [J].
Attaran, A ;
Gillespie-White, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (15) :1886-1892
[9]   THE ESTIMATION OF PREWAR GROSS NATIONAL PRODUCT - METHODOLOGY AND NEW EVIDENCE [J].
BALKE, NS ;
GORDON, RJ .
JOURNAL OF POLITICAL ECONOMY, 1989, 97 (01) :38-92
[10]  
Batson A, 2001, B WORLD HEALTH ORGAN, V79, P721